---
layout: post
title: "Study: 93 percent of advanced leukemia patients in remission after immunotherapy"
date: 2016-04-27 04:00:00
categories: Technology
author: unknown author
tags: [Cancer, Leukemia, Immune system, Fred Hutchinson Cancer Research Center, T cell, Immunotherapy, Medical specialties, Clinical medicine, Medicine, Health sciences, Health, Diseases and disorders, Life sciences, Immunology, Biology]
---


#### Digest
>digest unavailable

#### Extract
>(Fred Hutchinson Cancer Research Center) Twenty-seven of 29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells (disease-fighting immune cells) were genetically engineered to fight their cancers. This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer)....

#### Factsheet
>factsheet unavailable

[Visit Link](http://www.eurekalert.org/pub_releases/2016-04/fhcr-s9p042716.php)


